Cell and Advanced Therapies Supply Chain Management Market, 2020-2030
To order this 510+
page report, please visit this - https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html
Key Inclusions
§
An insightful company competitiveness analysis, taking into
consideration the supplier power (based on their employee base and years of
experience in the industry) and portfolio-related parameters, such as number of
software solutions offered, affiliated modes of deployment, scale of
management, end users, applications, regulatory certifications /
accreditations, support services offered, and key platform specifications and
benefits.
§
Comprehensive profiles of industry players that are
currently offering software solutions for supply chain management, featuring an
overview of the company, its financial information (if available), and a detailed description of its software
system(s). Each profile also includes a list of recent developments,
highlighting the key achievements, partnership activity, and the likely
strategies that may be adopted by these players to fuel growth, in the foreseen
future.
§
A detailed review of the cell and advanced therapies supply
chain, offering insights on the processes associated with various stages, such
as donor eligibility assessment, sample collection, manufacturing, logistics,
and patient verification and treatment follow-up, along with information on
cost requirements and existing opportunities for improvement in the supply chain
management practices.
§
A qualitative assessment of the current and long-term needs
of different stakeholders (patients, healthcare providers, collection centers,
manufacturers, logistics service providers and regulators / payers) involved in
the cell and advanced therapies supply chain, featuring a summary of the
diverse needs and areas of concern, along with our opinion (based on past and prevalent trends) on
how the industry is preparing to address such issues.
§
An analysis of the investments made at various stages of
development, such as seed financing, venture capital financing, debt financing,
grants, capital raised from IPOs and subsequent offerings received by companies
that are engaged in this field.
§
An analysis of the partnerships that have been established
in the domain, in the period between 2014 and Q3 2019, covering software
licensing agreements, mergers and acquisitions, product development agreements,
product integration agreements, distribution agreements, asset purchase
agreements, and other relevant deals.
§
A detailed analysis of the platform utilization use cases
where aforementioned software systems were leveraged by various stakeholders in
the domain, in the period between 2014 and Q3 2019, highlighting the ways in
which companies have implemented such systems to improve / optimize various
supply chain-related processes of cell and advanced therapies.
§
An in-depth analysis of the cost saving potential across
various processes of the cell and advanced therapies supply chain that can be
brought about by the implementation of bespoke and integrated technological
solutions / software systems.
The USD 1.5 billion (by 2030) financial opportunity
within the cell and advanced therapies supply chain management market has been analysed across the following
segments:
§ Application
area
§ Sample
collection and processing
§ Manufacturing
§ Logistics
§ Patient
identification and treatment follow-up
§ Type
of software solution
§ Cell
orchestration platform
§ Enterprise
manufacturing system
§ Inventory
management system
§ Laboratory
information management system
§ Logistics
management system
§ Patient
management system
§ Quality
management system
§ Mode
of Deployment
§ Cloud-based
solution
§ On-premises
solution
§ Scale
of Operation
§ Clinical
§ Commercial
§ End
user
§ Biobank
§ Cell
therapy lab / commercial organization
§ Hospital
/ medical center
§ Research
institute
§ Key
geographical regions
§ North
America
§ Europe
§ Asia
Pacific
§ Rest
of the world
To
request a sample pages, please visit this - https://www.rootsanalysis.com/reports/260/request-sample.html
Key
Questions Answered
§ What
are the trending software solutions for the management of cell and advanced
therapies supply chain?
§ Who
are the leading industry and non-industry players in this domain?
§ What
are the key challenges faced by various stakeholders in this domain?
§ What
kind of partnership models are commonly adopted by stakeholders in this
industry?
§ Who
are the key investors in this field?
§ What
is the current and likely future cost saving opportunities associated with
supply chain management solutions?
§ How
is the current and future market opportunity likely to be distributed across
key market segments and geographies?
§
What factors are likely to influence the evolution of this
upcoming market?
You may also be
interested in the following titles:
1. Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019 – 2030
2. Stem Cell Therapy Contract Manufacturing Market, 2019-2030
3. Cell and Gene Therapy CROs
Market, 2018-2030
About Roots Analysis
Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are driven
by an experienced leadership team which has gained many years of significant
experience in this sector. If you’d like help with your growing business needs,
get in touch at info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
Comments
Post a Comment